Literature DB >> 9032662

Growth hormone, insulin-like growth factor I, and motoneuron size.

L Chen1, P K Lund, S B Burgess, B E Rudisch, D L McIlwain.   

Abstract

In this study we asked whether growth hormone (GH) and one of its key mediators, insulin-like growth factor I (IGF-I), influence spinal motoneuron size in conjunction with whole body size. We present evidence that GH has such a role, possibly without the mediation of IGF-I. Both lumbar motoneuron and body size were found to be increased relative to littermate controls in transgenic mice overexpressing GH, while body size, but not motoneuron size, was increased in mice overexpressing IGF-I. GH overexpression coordinately increased nucleolar, nuclear, and cell body size in lumbar spinal motoneurons, so that their normal size relationships were preserved in the transgenic mice. In addition, spinal cord and brain weights were significantly increased in both types of transgenic animal. We conclude that GH can regulate motoneuron, central nervous system, and body size in the same animal, and that IGF-I can mimic the effects of GH on at least two of these three parameters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032662

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  11 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?

Authors:  Stefano Belli; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Insulin-like growth factor 1 physiology: lessons from mouse models.

Authors:  Shoshana Yakar; Martin L Adamo
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

Review 4.  Neural growth hormone: an update.

Authors:  Steve Harvey; Kerry Hull
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

5.  Abnormalities of the axial and proximal appendicular skeleton in adults with Laron syndrome (growth hormone insensitivity).

Authors:  L Kornreich; O Konen; M Schwarz; Y Siegel; G Horev; I Hershkovitz; Z Laron
Journal:  Skeletal Radiol       Date:  2007-11-09       Impact factor: 2.199

6.  Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.

Authors:  Sarah Knippenberg; Nadine Thau; Reinhard Dengler; Thomas Brinker; Susanne Petri
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

7.  The role of the cytoskeleton in cell body enlargement, increased nuclear eccentricity and chromatolysis in axotomized spinal motor neurons.

Authors:  David L McIlwain; Victoria B Hoke
Journal:  BMC Neurosci       Date:  2005-03-17       Impact factor: 3.288

8.  The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons.

Authors:  Jin-Young Chung; Hyun-Jung Kim; Manho Kim
Journal:  BMC Neurosci       Date:  2015-02-06       Impact factor: 3.288

9.  Growth Hormone (GH) and Rehabilitation Promoted Distal Innervation in a Child Affected by Caudal Regression Syndrome.

Authors:  Jesús Devesa; Alba Alonso; Natalia López; José García; Carlos I Puell; Tamara Pablos; Pablo Devesa
Journal:  Int J Mol Sci       Date:  2017-01-23       Impact factor: 5.923

10.  Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist.

Authors:  D L McIlwain; V B Hoke; J J Kopchick; C R Fuller; P K Lund
Journal:  BMC Neurosci       Date:  2004-02-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.